Centre Hospitalier Du Puy

At Centre Hospitalier Du Puy, clinical research in nephrology and cardiovascular diseases focuses on conditions such as immunoglobulin A nephropathy, chronic kidney disease, acute kidney injury, and broader heart and blood vessel disease. These studies are designed to test new treatment options, slow kidney function loss, and reduce major cardiovascular events in people at elevated risk.

• Immunoglobulin A nephropathy and proteinuria reduction
• Chronic kidney disease with high blood pressure and cardiovascular risk
• Acute kidney injury recovery and long-term outcomes
• Cardiovascular disease prevention in advanced kidney disease

Much of this work explores whether newer therapies can better protect kidney function while also improving overall cardiovascular health.

The site also supports trials in immune system diseases, especially rheumatoid arthritis. Research here is aimed at finding more effective ways to control persistent inflammation and improve symptoms in patients whose disease has not responded well to standard care.

• Rheumatoid arthritis with refractory disease
• Immune system processes involved in treatment response
• Combination treatment strategies for better disease control

These studies help clarify whether newer immune-targeted approaches can offer stronger and more lasting relief.

Clinical trials in neoplasms at this hospital include research in breast cancer, colon carcinoma, and follicular lymphoma. The main goals are to improve treatment effectiveness, refine cancer management after diagnosis, and support better outcomes for patients with advanced or recurrent disease.

• Estrogen receptor-positive, HER2-negative breast cancer
• Colon cancer and tumor DNA-guided treatment decisions
• Follicular lymphoma and combined therapy approaches
• Venous thromboembolism in patients with cancer

These studies reflect a strong interest in both direct cancer treatment and the prevention of complications that can affect people living with cancer.

Another important area of research involves hemic and lymphatic diseases and vascular medicine, including studies of venous thromboembolism, stroke, and other major vascular events. The purpose is to evaluate whether new blood-thinning strategies can better prevent recurrence and reduce serious complications.

• Venous thromboembolism in cancer-associated conditions
• Stroke and recurrent vascular event prevention
• Myocardial infarction and related cardiovascular outcomes

At Centre Hospitalier Du Puy, this research supports safer and more effective prevention strategies for patients at high risk of clotting events.

Within the infectiology department, the site is also involved in research on respiratory tract diseases and infection prevention, including work related to pneumococcal infection. These trials are focused on strengthening immune protection and assessing how well vaccination performs in people with increased infection risk.

• Pneumococcal vaccine response in high-risk adults
• Immune response during and after febrile illness
• Prevention of invasive bacterial infection

This area of research helps improve practical vaccination strategies for patients who may be more vulnerable to serious infections.